X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Andrology

期刊標題檢索 ANDROLOGY-US 最新評論: Review Speed: 2.0 | Submission Hit Rate: 50.0 Experience Sharing: ... (2024-03-07)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Andrology]您好,您是該頁面的第 26830 位訪客。

期刊簡介
期刊名稱Andrology Andrology
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.1

Speed
9.7

期刊簡稱ANDROLOGY-US
ISSN2047-2919
E-ISSN2047-2927
h-index31
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.101.0021.169
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Reproductive Medicine
Q16 / 90
Category: Medicine
Subcategory: Urology
Q18 / 120
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q137 / 244
Category: Medicine
Subcategory: Endocrinology
Q122 / 128

自引率 (2023-2024)9.40%自引率趨勢
掲載範囲
Andrology is the study of the male reproductive system and other male gender related health issues. Andrology deals with basic and clinical aspects of the male reproductive system (gonads, endocrine and accessory organs) in all species, including the diagnosis and treatment of medical problems associated with sexual development, infertility, sexual dysfunction, sex hormone action and other urological problems. In medicine, Andrology as a specialty is a recent development, as it had previously been considered a subspecialty of urology or endocrinology
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2047-2927
在線稿件提交https://mc.manuscriptcentral.com/andrology
開放訪問No
出版商John Wiley and Sons Inc.
主題領域ANDROLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數187每年文章數趨勢
黃金OA百分比29.59%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ANDROLOGYSCIEQ12/8
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2047-2919%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Andrology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE641168
    BIOMATERIALS579859
    BIOMEDICINE & PHARMACOTHERAPY498390
    Frontiers in Pharmacology489121
    JOURNAL OF ETHNOPHARMACOLOGY479884
    Journal of Materials Chemistry B476068
    Frontiers in Immunology458199
    COLLOIDS AND SURFACES B-BIOINTERFACES419266
    COMPUTERS IN BIOLOGY AND MEDICINE416781
    Frontiers in Oncology413590
  •  

    Andrology Andrology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Andrology] 的評論撰寫評論
作者: 东风晨濡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 13:38:53 評論於
Review Speed: 2.0 | Submission Hit Rate: 50.0
Experience Sharing: Ongoing
(0) 讚! | 东风晨濡

作者: 东风晨濡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-01 10:42:33 評論於
Review speed: 1.0 | Submission success rate: 50.0
Experience sharing: When submitting
(0) 讚! | 东风晨濡

作者: 莲花宛芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-27 17:32:54 評論於
Review speed: 3.0 | Submission hit rate: 25.0
Research focus: Prostate
Experience sharing: The magazine currently requests institutional mailing addresses, how can I provide this?
(0) 讚! | 莲花宛芹

作者: 云来秀爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-05 10:11:55 評論於
Is the magazine very strict about the original data?
(0) 讚! | 云来秀爱

作者: 仲夏运伟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-19 11:16:44 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 50.0
Experience Sharing: awaiting EIC decision, only one reviewer has comments. Not sure if it will be accepted, fingers crossed!
(0) 讚! | 仲夏运伟

作者: 仲夏运伟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-27 22:40:56 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: Feels like a good journal, still awaiting AE recommendation for several days. Hope for a good result!
(0) 讚! | 仲夏运伟

作者: 吉尔鲍比


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-20 23:32:15 評論於
I wrote an article on the basics of erectile dysfunction and felt that the amount of data was quite large. However, the editor rejected it because there was no functional data. I clearly had measured functional data, maybe they just didn't look closely
(0) 讚! | 吉尔鲍比

作者: 南方的狼


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2019-07-27 19:09:51 評論於
The external experts replied within 18 days for the first review, 15 days after the revision, and 2 days after the minor revision, and it was accepted. The work efficiency is super good.

(16) 讚! | 南方的狼

作者: Horace Mike


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-26 19:11:36 評論於
Review Speed: 1.0 Experience Sharing: Experts from other institutes took 18 days to reply after the initial review, 15 days to reply after major revisions, and 2 days to reply after minor revisions before acceptance. The efficiency is really impressive
(0) 讚! | Horace Mike

作者: 兰花婉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-02 13:42:08 評論於
Submitted an article in March this year, got rejected by the journal three days later, saying there was severe plagiarism in the sentences and requesting a rewrite. The revised article was marked with various colors, presumably automatically modified by software, mainly in the methodology, with many repeated sentences from my previous article. Had to spend a night revising it before resubmitting. Thought of submitting to Asian Andrology after getting rejected, after all, they have upgraded to over 3 points this year. Unexpectedly, a month and a half later, Andrology replied directly accepting it, this is too fast
(0) 讚! | 兰花婉容

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 16:31:37 評論於
There haven't been any big changes this year, let's see how it goes in the future
(0) 讚! | 凌霄高洁

作者: 恨瑶酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-10 15:23:53 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0
Sharing experience: Later submitted another article. The first review took half a month, and it was accepted in five days after the second review. Now, I am still working on improving the image clarity. Overall, I feel it's not so easy to submit
(0) 讚! | 恨瑶酱大魔王

作者: 重阳高潮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-03-31 15:17:02 評論於
Review Speed: 1.0 | Submission Success Rate: 50.0
Experience Sharing: New merged journal, currently no Impact Factor
(0) 讚! | 重阳高潮

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Andrology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*